Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bayer
National Institutes of Health Clinical Center (CC)
The Methodist Hospital Research Institute
Daiichi Sankyo
Mayo Clinic
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
Merck Sharp & Dohme LLC
pharmaand GmbH
M.D. Anderson Cancer Center
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Seagen Inc.
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
GlaxoSmithKline